Ceftriaxone & Tazobactam Injection 562.5 mg Supplier for Washington, USA
Premium Dual-Action Antibiotic Injection from India
Ernest Oncology offers Ceftriaxone & Tazobactam Injection 562.5 mg, a sterile injectable antibiotic containing Ceftriaxone 500 mg and Tazobactam 62.5 mg. Manufactured in India under WHO-GMP certified pharmaceutical facilities, this formulation is produced using advanced sterile manufacturing technology and stringent quality standards to ensure safety, purity, and consistent performance.
The medicine is designed for intramuscular (IM) or intravenous (IV) administration under the supervision of qualified healthcare professionals.
Washington Pharmaceutical Market Information
Washington is recognized for its advanced healthcare infrastructure, modern hospitals, and specialist medical facilities that emphasize high-quality pharmaceutical products. Injectable antibiotics manufactured according to internationally accepted quality standards continue to play an important role in supporting healthcare services.
India has earned worldwide recognition for manufacturing reliable pharmaceutical products through advanced technology, regulatory compliance, and internationally accepted quality systems.
Why Choose Indian Pharmaceutical Exports
India is one of the world's leading pharmaceutical manufacturing nations, supplying medicines to healthcare systems across the globe.
Benefits of Indian Pharmaceutical Manufacturing
- WHO-GMP certified manufacturing plants
- Advanced sterile production facilities
- International quality compliance
- High pharmaceutical purity
- Reliable manufacturing consistency
- Modern quality assurance systems
- Export-standard packaging
- Continuous product quality monitoring
- Globally trusted pharmaceutical expertise
- Innovation-driven manufacturing
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 562.5 mg |
| Composition | Ceftriaxone 500 mg + Tazobactam 62.5 mg |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Ceftriaxone and Tazobactam combination
- Broad-spectrum antibacterial formulation
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable formulation
- Reliable batch consistency
- Export-quality packaging
- Manufactured using advanced pharmaceutical technology
- International quality standards
Product Description
Ceftriaxone & Tazobactam Injection 562.5 mg combines Ceftriaxone, a third-generation cephalosporin antibiotic, with Tazobactam, a beta-lactamase inhibitor. This combination is formulated to enhance antibacterial effectiveness by protecting Ceftriaxone against beta-lactamase enzymes produced by certain bacteria.
The medicine is supplied as a sterile powder for injection and should be administered through intramuscular (IM) or intravenous (IV) injection by qualified healthcare professionals.
Mechanism of Action
The active ingredients provide complementary antibacterial activity.
- Ceftriaxone inhibits bacterial cell wall synthesis, leading to bacterial cell destruction.
- Tazobactam inhibits beta-lactamase enzymes, helping preserve the antibacterial activity of Ceftriaxone against susceptible bacteria.
Together, they offer broader antibacterial coverage when prescribed appropriately.
Recommended Dosage
Dosage should always be determined by a qualified healthcare professional.
Treatment depends on:
- Type of infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Overall clinical condition
The medicine should only be administered under medical supervision.
Side Effects
Some patients may experience temporary side effects.
Possible reactions include:
- Injection site discomfort
- Nausea
- Vomiting
- Diarrhea
- Headache
- Fever
- Skin rash
- Dizziness
- Allergic reactions
- Temporary elevation of liver enzymes
Seek medical attention if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Administer only under qualified medical supervision.
- Inform your healthcare provider about any allergies before treatment.
- Complete the prescribed antibiotic course.
- Follow all physician instructions carefully.
- Keep out of reach of children.
- Do not use after the expiry date.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in the original packaging
- Do not freeze
- Use before the expiry date
Quality Assurance
Each batch supplied by Ernest Oncology is manufactured under internationally recognized pharmaceutical quality systems.
Our Quality Promise
- WHO-GMP certified manufacturing facilities
- Sterile production environment
- Comprehensive batch testing
- Product traceability
- Export-grade packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality monitoring
Documentation
The following export documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where applicable)
- Batch Manufacturing Record* (where available)
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
Ernest Oncology is committed to improving global healthcare by providing pharmaceutical products manufactured to internationally accepted quality standards. Through scientific innovation, modern manufacturing technology, and strict quality control, we strive to deliver reliable medicines that support better patient care across the world.
Frequently Asked Questions (FAQs)
1. What does Ceftriaxone & Tazobactam Injection 562.5 mg contain?
It contains Ceftriaxone 500 mg and Tazobactam 62.5 mg in a sterile injectable formulation.
2. How is the injection administered?
It is administered by intramuscular (IM) or intravenous (IV) injection under the supervision of qualified healthcare professionals.
3. What is the purpose of Tazobactam in this combination?
Tazobactam inhibits beta-lactamase enzymes, helping protect Ceftriaxone and improve its antibacterial activity.
4. How should Ceftriaxone & Tazobactam Injection 562.5 mg be stored?
Store below 25°C, protected from moisture and direct sunlight, in its original packaging.
5. Is this medicine available without a prescription?
No. It is a prescription-only medicine and should only be used under medical supervision.
📞 Contact Ernest Oncology — Pharmaceuticals Medicine Supplier
A Specialized Healthcare Brand of Ernest Pharmaceutical Pvt. Ltd.
🌐 Visit Our Healthcare Platforms
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
Email: exports@ernestpharmaceuticals.com
🌍 Our Mission
- Advancing Pharmaceutical Innovation
- Delivering Quality Healthcare Solutions
- Trusted Medicines Manufactured in India
- Supporting Better Patient Care Worldwide
+91 93599 02383
Medical Disclaimer
Ceftriaxone & Tazobactam Injection 562.5 mg is a prescription-only medicine. The information provided on this page is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using this medicine. Product availability and regulatory requirements may vary according to country-specific regulations.
Description
Ernest Oncology supplies Ceftriaxone & Tazobactam Injection 562.5 mg from India to Washington, USA. WHO-GMP manufactured sterile antibiotic injection delivering reliable pharmaceutical quality and trusted healthcare solutions.
- Ceftriaxone Sodium & Tazobactam Sodium Injection
- Ceftriaxone & Tazobactam Sterile Powder for Injection
- Ceftriaxone & Tazobactam IM/IV Injection
- Ceftriaxone & Tazobactam Dry Powder Injection
- Ceftriaxone & Tazobactam Broad-Spectrum Antibiotic Injection
Written By
Chaitali H.
B. Pharma
